Relação entre a suscetibilidade de Candida spp a anfotericina B, com óbito ou sobrevivência dos pacientes em episódios de candidemia
| Ano de defesa: | 2007 |
|---|---|
| Autor(a) principal: | |
| Orientador(a): | |
| Banca de defesa: | |
| Tipo de documento: | Dissertação |
| Tipo de acesso: | Acesso aberto |
| dARK ID: | ark:/26339/001300000kr63 |
| Idioma: | por |
| Instituição de defesa: |
Universidade Federal de Santa Maria
BR Farmácia UFSM Programa de Pós-Graduação em Ciências Farmacêuticas |
| Programa de Pós-Graduação: |
Não Informado pela instituição
|
| Departamento: |
Não Informado pela instituição
|
| País: |
Não Informado pela instituição
|
| Palavras-chave em Português: | |
| Link de acesso: | http://repositorio.ufsm.br/handle/1/5954 |
Resumo: | Among fungal infections, those caused by Candida spp are the most recurrent. Candidaemias are the most emergent and amphotericin B has been the mainstay of therapy in spite of its therapeutic failures. Because of these limitations, susceptibility testing of fungi against antifungal agents has been evidencing a great importance in order to confirm susceptibility to the used antifungal agents. In this study, 144 Candida spp isolates from immunocompromised patients, that either evolved into death (Group 1) or survived to candidaemia episodes (Group 2), were assessed. Tests were made according to proceedings and culture media described on M27-A2 document currently provided by Clinical and Laboratory Standards Institute (CLSI). Media such as Yeast Nitrogen Base- dextrose (YNBd) and Antibiotic Medium were also tested, being used a higher number of Amphotericin B concentrations. Susceptibility values of strains from Group 1 were significantly higher than Group 2 when Antibiotic Medium 3 (AM3) and YNBd were used. The Minimal Inhibitory Concentration (MIC) and Minimal Fungicidal Concentration (MFC) media values for strains from patients that survived to candidaemia were, respectively, 0.5 μg/dL and 0.7 μg/dL; whereas MIC and MFC media values for strains from patients that evolved into death were, respectively, 0.6 μg/dL and 0.9 μg/dL. Significant differences were not observed between the two groups of strains when using RPMI 1640 medium. |
| id |
UFSM_53203cbe2ed6244dcc48ad9dee0a0124 |
|---|---|
| oai_identifier_str |
oai:repositorio.ufsm.br:1/5954 |
| network_acronym_str |
UFSM |
| network_name_str |
Manancial - Repositório Digital da UFSM |
| repository_id_str |
|
| spelling |
Relação entre a suscetibilidade de Candida spp a anfotericina B, com óbito ou sobrevivência dos pacientes em episódios de candidemiaRelationship between susceptibility of Candida spp isolates to amphotericin B, and death or survival of patients on candidaemia episodesAnfotericina BCandidemiaSuscetibilidadeAnphotericin BCandidaemiaSusceptibilityCNPQ::CIENCIAS DA SAUDE::FARMACIAAmong fungal infections, those caused by Candida spp are the most recurrent. Candidaemias are the most emergent and amphotericin B has been the mainstay of therapy in spite of its therapeutic failures. Because of these limitations, susceptibility testing of fungi against antifungal agents has been evidencing a great importance in order to confirm susceptibility to the used antifungal agents. In this study, 144 Candida spp isolates from immunocompromised patients, that either evolved into death (Group 1) or survived to candidaemia episodes (Group 2), were assessed. Tests were made according to proceedings and culture media described on M27-A2 document currently provided by Clinical and Laboratory Standards Institute (CLSI). Media such as Yeast Nitrogen Base- dextrose (YNBd) and Antibiotic Medium were also tested, being used a higher number of Amphotericin B concentrations. Susceptibility values of strains from Group 1 were significantly higher than Group 2 when Antibiotic Medium 3 (AM3) and YNBd were used. The Minimal Inhibitory Concentration (MIC) and Minimal Fungicidal Concentration (MFC) media values for strains from patients that survived to candidaemia were, respectively, 0.5 μg/dL and 0.7 μg/dL; whereas MIC and MFC media values for strains from patients that evolved into death were, respectively, 0.6 μg/dL and 0.9 μg/dL. Significant differences were not observed between the two groups of strains when using RPMI 1640 medium.Dentre as infecções fúngicas, aquelas provocadas por Candida spp são as mais recorrentes, sendo as candidemias a forma mais emergente, cujo tratamento mais utilizado tem sido à base de anfotericina B, apesar das falhas terapêuticas a esse poliênico. Devido a tais falhas, os testes de avaliação da suscetibilidade de fungos a agentes antifúngicos passam a ter grande importância para confirmar a suscetibilidade aos agentes antifúngicos usados. Neste estudo foram avaliadas 144 isolados de Candida spp, oriundas de pacientes imunodeprimidos que evoluíram ao óbito ou que sobreviveram aos episódios de candidemia. Os testes foram realizados de acordo com os procedimentos e meios de cultura descritos no documento M27-A2 do atual Clinical and Laboratory Standards Institute (CLSI). Testou-se também os meios Yeast Nitrogen Base dextrosado (YNBd) e Antibiotic Médium 3 (AM3) sendo utilizado um número maior de concentrações de anfotericina B. Os valores de suscetibilidade das cepas provenientes dos pacientes que evoluíram ao óbito foram significativamente maiores que os valores obtidos dos pacientes que sobreviveram a candidemia quando os meios utilizados foram o Antibiotic Médium 3 (AM3) e o YNBd, nos quais encontrou-se valores médios de Concentração Inibitória Mínima (CIM) igual a 0,5 μg/dL e valores de Concentração Fungicida Mínima (CFM) igual a 0,7 μg/dL para pacientes que sobreviveram a candidemia; valores médios de CIM igual a 0,6 μg/dL e de CFM igual a 0,9 μg/dL foram encontrados nas cepas dos pacientes que evoluiram ao óbito. Com o meio de cultura RPMI 1640 não foram observadas diferenças significativas nos valores de suscetibilidade entre os dois grupos de pacientes.Universidade Federal de Santa MariaBRFarmáciaUFSMPrograma de Pós-Graduação em Ciências FarmacêuticasAlves, Sydney Hartzhttp://lattes.cnpq.br/0330782478769631Santurio, Janio Moraishttp://lattes.cnpq.br/6316012260769979Horner, Rosmarihttp://lattes.cnpq.br/5907084134183708Boff, Everton2007-05-072007-05-072007-01-22info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfapplication/pdfBOFF, Everton. Relationship between susceptibility of Candida spp isolates to amphotericin B, and death or survival of patients on candidaemia episodes. 2007. 76 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2007.http://repositorio.ufsm.br/handle/1/5954ark:/26339/001300000kr63porinfo:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2023-01-02T11:45:03Zoai:repositorio.ufsm.br:1/5954Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/PUBhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.com||manancial@ufsm.bropendoar:2023-01-02T11:45:03Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false |
| dc.title.none.fl_str_mv |
Relação entre a suscetibilidade de Candida spp a anfotericina B, com óbito ou sobrevivência dos pacientes em episódios de candidemia Relationship between susceptibility of Candida spp isolates to amphotericin B, and death or survival of patients on candidaemia episodes |
| title |
Relação entre a suscetibilidade de Candida spp a anfotericina B, com óbito ou sobrevivência dos pacientes em episódios de candidemia |
| spellingShingle |
Relação entre a suscetibilidade de Candida spp a anfotericina B, com óbito ou sobrevivência dos pacientes em episódios de candidemia Boff, Everton Anfotericina B Candidemia Suscetibilidade Anphotericin B Candidaemia Susceptibility CNPQ::CIENCIAS DA SAUDE::FARMACIA |
| title_short |
Relação entre a suscetibilidade de Candida spp a anfotericina B, com óbito ou sobrevivência dos pacientes em episódios de candidemia |
| title_full |
Relação entre a suscetibilidade de Candida spp a anfotericina B, com óbito ou sobrevivência dos pacientes em episódios de candidemia |
| title_fullStr |
Relação entre a suscetibilidade de Candida spp a anfotericina B, com óbito ou sobrevivência dos pacientes em episódios de candidemia |
| title_full_unstemmed |
Relação entre a suscetibilidade de Candida spp a anfotericina B, com óbito ou sobrevivência dos pacientes em episódios de candidemia |
| title_sort |
Relação entre a suscetibilidade de Candida spp a anfotericina B, com óbito ou sobrevivência dos pacientes em episódios de candidemia |
| author |
Boff, Everton |
| author_facet |
Boff, Everton |
| author_role |
author |
| dc.contributor.none.fl_str_mv |
Alves, Sydney Hartz http://lattes.cnpq.br/0330782478769631 Santurio, Janio Morais http://lattes.cnpq.br/6316012260769979 Horner, Rosmari http://lattes.cnpq.br/5907084134183708 |
| dc.contributor.author.fl_str_mv |
Boff, Everton |
| dc.subject.por.fl_str_mv |
Anfotericina B Candidemia Suscetibilidade Anphotericin B Candidaemia Susceptibility CNPQ::CIENCIAS DA SAUDE::FARMACIA |
| topic |
Anfotericina B Candidemia Suscetibilidade Anphotericin B Candidaemia Susceptibility CNPQ::CIENCIAS DA SAUDE::FARMACIA |
| description |
Among fungal infections, those caused by Candida spp are the most recurrent. Candidaemias are the most emergent and amphotericin B has been the mainstay of therapy in spite of its therapeutic failures. Because of these limitations, susceptibility testing of fungi against antifungal agents has been evidencing a great importance in order to confirm susceptibility to the used antifungal agents. In this study, 144 Candida spp isolates from immunocompromised patients, that either evolved into death (Group 1) or survived to candidaemia episodes (Group 2), were assessed. Tests were made according to proceedings and culture media described on M27-A2 document currently provided by Clinical and Laboratory Standards Institute (CLSI). Media such as Yeast Nitrogen Base- dextrose (YNBd) and Antibiotic Medium were also tested, being used a higher number of Amphotericin B concentrations. Susceptibility values of strains from Group 1 were significantly higher than Group 2 when Antibiotic Medium 3 (AM3) and YNBd were used. The Minimal Inhibitory Concentration (MIC) and Minimal Fungicidal Concentration (MFC) media values for strains from patients that survived to candidaemia were, respectively, 0.5 μg/dL and 0.7 μg/dL; whereas MIC and MFC media values for strains from patients that evolved into death were, respectively, 0.6 μg/dL and 0.9 μg/dL. Significant differences were not observed between the two groups of strains when using RPMI 1640 medium. |
| publishDate |
2007 |
| dc.date.none.fl_str_mv |
2007-05-07 2007-05-07 2007-01-22 |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
| format |
masterThesis |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
BOFF, Everton. Relationship between susceptibility of Candida spp isolates to amphotericin B, and death or survival of patients on candidaemia episodes. 2007. 76 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2007. http://repositorio.ufsm.br/handle/1/5954 |
| dc.identifier.dark.fl_str_mv |
ark:/26339/001300000kr63 |
| identifier_str_mv |
BOFF, Everton. Relationship between susceptibility of Candida spp isolates to amphotericin B, and death or survival of patients on candidaemia episodes. 2007. 76 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2007. ark:/26339/001300000kr63 |
| url |
http://repositorio.ufsm.br/handle/1/5954 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Universidade Federal de Santa Maria BR Farmácia UFSM Programa de Pós-Graduação em Ciências Farmacêuticas |
| publisher.none.fl_str_mv |
Universidade Federal de Santa Maria BR Farmácia UFSM Programa de Pós-Graduação em Ciências Farmacêuticas |
| dc.source.none.fl_str_mv |
reponame:Manancial - Repositório Digital da UFSM instname:Universidade Federal de Santa Maria (UFSM) instacron:UFSM |
| instname_str |
Universidade Federal de Santa Maria (UFSM) |
| instacron_str |
UFSM |
| institution |
UFSM |
| reponame_str |
Manancial - Repositório Digital da UFSM |
| collection |
Manancial - Repositório Digital da UFSM |
| repository.name.fl_str_mv |
Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM) |
| repository.mail.fl_str_mv |
atendimento.sib@ufsm.br||tedebc@gmail.com||manancial@ufsm.br |
| _version_ |
1847153414976307200 |